Efficacy and Safety of Beclomethasone Dipropionate in Patients 12 Years of Age and Older With Asthma

- Persistent Asthma
- Completed

Study Title: Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Teva Identifier: BDB-AS-30039 | 2015-002510-80

ClinicalTrials.gov Identifier: NCT02513160

Study Status: Completed

Trial Condition(s): Persistent Asthma

Interventions: Drug: Beclomethasone Dipropionate 640 | Drug: Placebo | Drug: Beclomethasone dipropionate via 320 mcg BAI | Drug: albuterol/salbutamol | Drug: Beclomethasone dipropionate via 320 mcg MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: September 30, 2015 - March 31, 2016

Phase: Phase 3

Study Type

Interventional